Systemic chemotherapy and survival in patients with metastatic low‐grade appendiceal mucinous adenocarcinoma

Abstract

Appendiceal cancer is a rare malignancy that exhibits a wide range of histology and treatment response. Given the rarity and heterogeneous nature of the disease, it has been difficult to define optimal treatment strategies. Our goal is to examine the association between use of systemic chemotherapy and survival in patients with metastatic low‐grade mucinous appendiceal adenocarcinoma.